Complete Pathologic Response When Adding Pembrolizumab to Neoadjuvant Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer

被引：5
|
作者：
Hill, Addie [1 ]
Gong, Jun [1 ]
Wilczynski, Sharon [1 ]
Mirza, Rizvan [1 ]
Erhunmwunsee, Loretta [1 ]
Salgia, Ravi [1 ]
机构：
[1] City Hope Canc Ctr, Duarte, CA USA
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2018年 / 14卷 / 09期
关键词：
D O I：
10.1200/JOP.18.00127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：569 / +
页数：5
相关论文
共 50 条
  • [21] Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases
    Li, Xin
    Xia, Chunqiu
    Liu, Minghui
    Liu, Jinghao
    Dong, Ming
    Zhao, Honglin
    Xu, Song
    Wang, Dan
    Wei, Sen
    Song, Zuoqing
    Chen, Gang
    Liu, Hongyu
    Chen, Jun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] Pembrolizumab in Non-Small-Cell Lung Cancer
    Sorscher, Steven
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (10): : 996 - 997
  • [23] A Case of Pathologic Complete Response to Neoadjuvant Chemotherapy and Pembrolizumab in Metaplastic Breast Cancer
    Gul, Anita
    Alberty-Oller, J. Jaime
    Sandhu, Jagbir
    Ayala-Bustamante, Everick
    Adams, Sylvia
    JCO PRECISION ONCOLOGY, 2023, 7
  • [24] The need for immunotherapy when neoadjuvant chemoradiotherapy achieves pathologic complete response in stage IIIB non-small cell lung cancer: a case report
    Lv, Changsheng
    Zhao, Lei
    Zhu, Yuntao
    Wang, Peng
    Sun, Zhe
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (04) : 4965 - 4969
  • [25] Pathologic response and safety to neoadjuvant PD-1 inhibitors and chemotherapy in resectable squamous non-small-cell Lung cancer
    Shi, Liang
    Meng, Qiyi
    Tong, Li
    Li, Hongxia
    Dong, Yujie
    Su, Chongyu
    Liu, Zhe
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer
    Bar, J.
    Urban, D.
    Redinsky, I.
    Ackerstein, A.
    Daher, S.
    Kamer, I.
    Onn, A.
    Shulimzon, T.
    Peled, M.
    Zeitlin, N.
    Kremer, R.
    Raskin, S.
    Ben-Nun, A.
    Perelman, M.
    Ofek, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S865 - S866
  • [27] Neoadjuvant chemoradiotherapy of stage III non-small-cell lung cancer
    Friedel, G
    Hruska, D
    Budach, W
    Wolf, M
    Kyriss, T
    Hürtgen, M
    Eulenbruch, HP
    Dierkesmann, R
    Toomes, H
    LUNG CANCER, 2000, 30 (03) : 175 - 185
  • [28] The effects of neoadjuvant chemotherapy with cisplatin and vinorelbine on the resectability of non small cell lung cancer stage IIIA/IIIB
    Spasova, I
    Havel, L
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 591 - 594
  • [29] Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non-small-cell lung cancer
    Han, Rui
    Zhang, Yimin
    Wang, Tianhu
    Xiao, Hualiang
    Luo, Zhilin
    Shen, Cheng
    Li, Jianghua
    Zhao, Chenglong
    Li, Li
    Zhu, Mengxiao
    Du, Haiwei
    Tang, Huan
    Ma, Zheng
    Wang, Yubo
    He, Yong
    CANCER SCIENCE, 2023, 114 (06) : 2569 - 2583
  • [30] Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer
    Thomas, DM
    Mitchell, PLR
    Berlangieri, SU
    Tochon-Danguy, H
    Knight, S
    Clarke, CP
    Scott, AM
    MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (04) : 227 - 227
12345